Modern medicine has been waging a war on cancer for nearly a century with no tangible
end in sight. Cancer treatments have significantly progressed, but the need to increase …

Background and purpose Stereotactic body radiotherapy (SBRT) is an emerging ablative
modality for hepatocellular carcinoma (HCC). This study aimed to synthesize available …

Methods A phase II, single-arm clinical trial on SBRT for small HCCs was conducted at an
academic tertiary care center. The planned SBRT dose was 45 Gy with a fraction size of 15 …

Original article breast, gastrointestinal, and urologic tu mors. Survival rates were reported to
be at 36 and 23% after 5 and 10 years. The best rates were reported for breast cancer and …

Radiation-induced liver disease (RILD) or radiation hepatitis is a sub-acute form of liver
injury due to radiation. It is one of the most dreaded complications of radiation which …

Hepatocellular carcinoma is the fourth leading cause of cancer-related death worldwide.
Depending on the extent of disease and competing comorbidities for mortality, multiple liver …

Stereotactic Body Radiation Therapy (SBRT) is an emerging effective treatment for
hepatocellular carcinoma (HCC) associated with acceptable rates of toxicity in appropriately …

Although stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy has
become an established standard of care for the treatment of a variety of malignancies, our …

Purpose To further explore the correlation of central biliary tract (cHBT) radiation doses with
hepatobiliary toxicity (HBT) after stereotactic body radiation therapy (SBRT) in a larger …

Background: Stereotactic body radiation therapy (SBRT) is an advanced technique of
external beam radiation therapy that delivers large ablative doses of radiation. In the past …